Platelet Endocytosis in Innate Immunity

先天免疫中的血小板内吞作用

基本信息

  • 批准号:
    9362971
  • 负责人:
  • 金额:
    $ 44.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

Surprisingly, platelets are capable of many cellular processes (i.e., RNA splicing, translation, glycosylation, endocytosis); however, their effects on platelet function are often unclear. As circulating sentries, platelets sample the vasculature via endocytosis. Some of the endocytosed cargo (i.e., fibrinogen) traffics to granules; however, other material initiates platelet responses. In this proposal, we show that pathogen endocytosis induces immuno- activation of platelets. This likely contributes to the increased cardiovascular risks associated with persistent infections, (as seen in HIV-1/AIDS patients). In this application, we build on our novel findings, hypothesizing that platelet endocytosis is critical for innate immune response to viral infections. To test this hypothesis, we focus on how platelet endocytosis facilitates Toll-like Receptor (TLR)-based signaling in an animal model that mimics chronic HIV-1/AIDS. Using novel, genetically-altered mice (Arf6-/-, VAMP-3-/-, and Syntaxin-2/4-/-), which are defective at different endocytic steps, we will address the roles, routes, and mechanisms of platelet endocytosis, with specific focus on how platelets interact with HIV-1 virus. We propose two specific aims: Aim 1. Determine the effects of defective platelet endocytosis on innate immune responses in a model of viremia. Aim 2. Determine the mechanisms and routes of the platelet endocytosis system. Our proposal advances platelets as active monitors of the vasculature, continuously interacting with and interpreting their environment while circulating. In this scenario, platelets use endocytosis to continuously sample their microenvironment and, through endocytic trafficking, process and evaluate cues that initiate responses to what the platelets have endocytosed. Our work will yield insights into platelet function during systemic infections, thus reshaping the uses of anti-thrombotic therapies. Finally, understanding platelet endocytosis will uncover novel strategies to increase the efficiency of loading platelets with therapeutics that can be used to treat CVD.
令人惊讶的是,血小板能够进行许多细胞过程(即RNA剪接,翻译,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SIDNEY Waldo WHITEHEART其他文献

SIDNEY Waldo WHITEHEART的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SIDNEY Waldo WHITEHEART', 18)}}的其他基金

2022 Hemostasis Gordon Research Conference and Seminar
2022戈登止血研究会议暨研讨会
  • 批准号:
    10468359
  • 财政年份:
    2022
  • 资助金额:
    $ 44.16万
  • 项目类别:
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
血栓形成和免疫中的血小板胞吐作用和内吞作用
  • 批准号:
    10377959
  • 财政年份:
    2020
  • 资助金额:
    $ 44.16万
  • 项目类别:
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
血栓形成和免疫中的血小板胞吐作用和内吞作用
  • 批准号:
    10604325
  • 财政年份:
    2020
  • 资助金额:
    $ 44.16万
  • 项目类别:
Platelet Exocytosis and Endocytosis in Thrombosis and Immunity
血栓形成和免疫中的血小板胞吐作用和内吞作用
  • 批准号:
    9894537
  • 财政年份:
    2020
  • 资助金额:
    $ 44.16万
  • 项目类别:
Targeting Platelet Endocytosis and Exocytosis to Control Thrombosis
靶向血小板胞吞作用和胞吐作用来控制血栓形成
  • 批准号:
    10046272
  • 财政年份:
    2017
  • 资助金额:
    $ 44.16万
  • 项目类别:
Targeting Platelet Endocytosis and Exocytosis to Control Thrombosis
靶向血小板胞吞作用和胞吐作用来控制血栓形成
  • 批准号:
    10392316
  • 财政年份:
    2017
  • 资助金额:
    $ 44.16万
  • 项目类别:
IMAGING CORE
成像核心
  • 批准号:
    8360572
  • 财政年份:
    2011
  • 资助金额:
    $ 44.16万
  • 项目类别:
IMAGING CORE
成像核心
  • 批准号:
    8168246
  • 财政年份:
    2010
  • 资助金额:
    $ 44.16万
  • 项目类别:
KY COBRE: IMAGING CORE
KY COBRE:成像核心
  • 批准号:
    7960493
  • 财政年份:
    2009
  • 资助金额:
    $ 44.16万
  • 项目类别:
ANTIBODY PRODUCTION AND MOUSE GENOTYPING CORE
抗体生产和小鼠基因分型核心
  • 批准号:
    7960500
  • 财政年份:
    2009
  • 资助金额:
    $ 44.16万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 44.16万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 44.16万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 44.16万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 44.16万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 44.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了